Medical Condition News

RSS

Research: Hypermutation in cancer is more frequent in inactive X chromosome

Every case of cancer originates from changes in a person's genetic material (mutations). These usually occur as "somatic mutations" in individual cells during an individual's lifetime, rather than being inherited from a person's parents.

19 Oct 2013

Study shows significant link between low dietary fiber intake and cardiometabolic risks

A new study published in the December issue of The American Journal of Medicine shows a significant association between low dietary fiber intake and cardiometabolic risks including metabolic syndrome, cardiovascular inflammation, and obesity.

19 Oct 2013

Boston Medical Center receives 2 research awards from PCORI to study delivery of cancer care

Boston Medical Center (BMC) has been approved to receive two research awards from the Patient-Centered Outcomes Research Institute (PCORI). One will study the delivery of cancer care to patients who face socio-legal barriers and the other will test the effectiveness of integrative medical group visits (IMGV) for treating chronic pain.

19 Oct 2013

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

The U.S. Food and Drug Administration today approved Opsumit (macitentan), a new drug to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive and debilitating disease that can lead to death or the need for lung transplantation.

19 Oct 2013

CBT more effective in reducing symptoms of health anxiety

Cognitive behavioural therapy (CBT) is substantially more effective than standard care at reducing symptoms of health anxiety in medical patients, and can be delivered by non-specialist staff with minimal training at little extra cost.

19 Oct 2013

ARIAD discontinues Phase 3 EPIC trial of Iclusig in patients with chronic myeloid leukemia

ARIAD Pharmaceuticals, Inc. today announced that it is discontinuing the Phase 3 EPIC (Evaluation of Ponatinib versus Imatinib in Chronic Myeloid Leukemia) trial of Iclusig (ponatinib) in patients with newly diagnosed chronic myeloid leukemia.

18 Oct 2013

Genalyte receives NCI grant to develop biomarker panel to profile TAA autoantibodies

Genalyte, Inc., today announced that it has received a $1 million SBIR grant from the National Cancer Institute to develop a biomarker panel to profile tumor antigen-associated autoantibodies.

18 Oct 2013

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adults with active ankylosing spondylitis.

18 Oct 2013

Motor neurone disease neck collars: an interview with Dr Christopher J McDermott, Clinical Senior Lecturer, University of Sheffield

The majority of the current neck support collars for MND patients were designed for a different purpose. So, if you think about when people are involved in a road traffic accident, the paramedics arrive and put a collar on to immobilize the neck and protect the spine. A lot of the collars that we give to our patients with MND were actually designed for that purpose - to immobilize the necks of people involved in trauma… and patients don't want that.

18 Oct 2013

Improving wellness for people living with mood disorders from childhood throughout adulthood

The Depression and Bipolar Support Alliance and The Balanced Mind Foundation are joining forces to improve the mental health of, and facilitate wellness for, individuals living with mood disorders from childhood throughout adulthood.

18 Oct 2013

$Vertebral augmentation for spinal fractures improves patient survival, reduces overall costs$

Vertebral augmentation for spinal fractures improves patient survival, reduces overall costs

A study of 69,000 Medicare patient records led by Johns Hopkins researchers shows that people with spine compression fractures who undergo operations to strengthen back bones with cement survive longer and have shorter overall hospital stays than those who stick with bed rest, pain control and physical therapy.

18 Oct 2013

Profound abnormalities in brain activity discovered in retired American football players

A new study has discovered profound abnormalities in brain activity in a group of retired American football players.

18 Oct 2013

Brain scientists to explore current biological, psychosocial and ecological aspects of memory loss disorders

"From Neurodegeneration to Brain Health: An Integrated Approach" is a conference that will bring together distinguished brain scientists to explore the current biological, psychosocial and ecological aspects of memory loss disorders.

18 Oct 2013

Altherx Pharmaceuticals receives U.S. patent for use of solabegron for treatment of overactive bladder

AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).

18 Oct 2013

Prevalence of depression is twice high among migraineurs

The prevalence of depression among those with migraine is approximately twice as high as for those without the disease (men: 8.4% vs. 3.4%; women 12.4% vs. 5.7%), according to a new study published by University of Toronto researchers.

18 Oct 2013

Traumatic injuries can be more severe for older adults, yet do not get right level of care

Traumatic injuries can be more severe for older adults, yet they often do not get the right level of care, according to a study appearing in the October issue of the Journal of the American College of Surgeons. Instead of going to a trauma center, many elderly patients end up in facilities without specialized expertise in trauma care that can treat all of their injuries.

18 Oct 2013

GenSpera to present G-202 Phase I trial in hepatocellular carcinoma at EORTC-NCI-AACR Symposium

GenSpera, Inc. (OTCBB:GNSZ) announced that Devalingam Mahalingam, MD, PhD, principal investigator of the G-202 Phase II trial in hepatocellular carcinoma, will present data from the G-202 Phase I clinical trial at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Boston, MA on Monday, October 21st.

18 Oct 2013

Scientists examine different animal species to solve some of the riddles of human diseases

What do pigs, jellyfish and zebrafish have in common? It might be hard to discern the connection, but the different species are all pieces in a puzzle. A puzzle which is itself part of a larger picture of solving the riddles of diseases in humans.

18 Oct 2013

UC Irvine's 90+ Study to continue for another five years

UC Irvine's trailblazing 90+ Study, launched in 2003 to learn more about the "oldest old," the fastest-growing age group in the U.S., will continue for at least another five years, thanks to a $9.5 million renewal grant from the National Institute on Aging.

18 Oct 2013

Gene variations in response to injury can impact clinical outcomes in TBI

Subtle variations in genes that regulate a person's inflammatory response to injury can impact clinical outcomes in TBI, according to a new study published in Journal of Neurotrauma.

18 Oct 2013

Medical Condition News

Research: Hypermutation in cancer is more frequent in inactive X chromosome

Study shows significant link between low dietary fiber intake and cardiometabolic risks

Boston Medical Center receives 2 research awards from PCORI to study delivery of cancer care

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

CBT more effective in reducing symptoms of health anxiety

ARIAD discontinues Phase 3 EPIC trial of Iclusig in patients with chronic myeloid leukemia

Genalyte receives NCI grant to develop biomarker panel to profile TAA autoantibodies

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

Motor neurone disease neck collars: an interview with Dr Christopher J McDermott, Clinical Senior Lecturer, University of Sheffield

Improving wellness for people living with mood disorders from childhood throughout adulthood

Vertebral augmentation for spinal fractures improves patient survival, reduces overall costs

Profound abnormalities in brain activity discovered in retired American football players

Brain scientists to explore current biological, psychosocial and ecological aspects of memory loss disorders

Altherx Pharmaceuticals receives U.S. patent for use of solabegron for treatment of overactive bladder

Prevalence of depression is twice high among migraineurs

Traumatic injuries can be more severe for older adults, yet do not get right level of care

GenSpera to present G-202 Phase I trial in hepatocellular carcinoma at EORTC-NCI-AACR Symposium

Scientists examine different animal species to solve some of the riddles of human diseases

UC Irvine's 90+ Study to continue for another five years

Gene variations in response to injury can impact clinical outcomes in TBI

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News